# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://nypost.com/2024/07/05/lifestyle/toxic-arsenic-and-lead-commonly-found-in-tampons-new-study/
Exane BNP Paribas analyst Kevin Grundy initiates coverage on Kimberly-Clark (NYSE:KMB) with a Neutral rating and announces P...
RBC Capital analyst Nik Modi reiterates Kimberly-Clark (NYSE:KMB) with a Outperform and maintains $165 price target.
Kimberly-Clark goes from Underperform to Buy; Anna Lizzul upgraded the rating and raised the price target from $115 to $160.
B of A Securities analyst Anna Lizzul upgrades Kimberly-Clark (NYSE:KMB) from Underperform to Buy and raises the price targe...